Review on Principles and Etiopathogenesis of Ameloblastoma

Authors

  • Mohapatra S Assistant Professor, Department of Public Health Dentistry, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune – 18.
  • Mohandas R Assistant Professor,Department of Oral and Maxillofacial Pathology and Oral Microbiology,Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune – 18.

DOI:

https://doi.org/10.56501/intjclinicopatholcorrel.v7i2.916

Keywords:

ameloblastoma, benign, etiopathogenesis, tumour, management

Abstract

Ameloblastoma, a rare odontogenic tumor that has fascinated clinicians and researchers for decades. This review delves into the tumor's origin, deeply investigating the etiopathogenesis rooted in the odontogenic epithelium associated with enamel formation. It elucidates key cellular and molecular mechanisms driving its development, shedding light on the intricate factors governing initiation and progression. Furthermore, the review focuses on the management of ameloblastoma, with an emphasis on surgical interventions. This review also addresses the vexing issue of tumor recurrence and the potential complications that can arise during and after treatment. By examining these issues in detail, it offers essential insights into effective strategies for managing these aspects of ameloblastoma, ensuring that clinicians and researchers are well-equipped to navigate the complexities of this unique odontogenic tumor. In summary, this review offers a holistic and in-depth exploration of ameloblastoma, from its origins to its management and the challenges it presents to the medical community.

References

Anyanechi CE, Shetty SS. Ameloblastoma of the jaws in adult: A retrospective review of local recurrent lesions based on the resection margin in the adjacent apparent healthy tissues. Heliyon. 2023 May;9(5):e16243.

Kono T, Abe A, Noguchi K, Uchida K, Shinoda M, Kawano K. Extragingival peripheral ameloblastoma arising in the infratemporal fossa: A case report with an assessment of proliferative activity. Oral Sci Int. 2023 Jan;20(1):36–41.

Black AI, Machete ML, Motloba PD. A 30-year review of ameloblastoma: A tertiary hospital-based study. South African Dental Journal. 2023 May 1;78(4):184-9.

Bwambale P, Yahaya JJ, Owor G, Wabinga H. Histopathological patterns and biological characteristics of ameloblastoma: A retrospective cross-sectional study. J Taibah Univ Med Sci. 2022 Feb;17(1):96–104.

Nagi R, Sahu S, Rakesh N. Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update. J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):497–504.

Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018 Apr;24(3):307–16.

Mishra P, Panda A, Bandyopadhyay A, Kumar H, Mohiddin G. Sonic Hedgehog Signalling Pathway and Ameloblastoma - A Review. J Clin Diagn Res. 2015 Nov;9(11):ZE10–3.

Carballo GB, Honorato JR, de Lopes GPF, Spohr TCL de SE. A highlight on Sonic hedgehog pathway. Cell Commun Signal. 2018 Mar 20;16(1):11.

MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009 Jul;17(1):9–26.

Nascimento MAB, Nonaka CFW, Barboza CAG, Freitas R de A, Pereira Pinto L, Souza LB de. Immunoexpression of BMP-2 and BMP-4 and their receptors, BMPR-IA and BMPR-II, in ameloblastomas and adenomatoid odontogenic tumors. Arch Oral Biol. 2017 Jan;73:223–9.

Karathanasi V, Tosios KI, Nikitakis NG, Piperi E, Koutlas I, Trimis G, et al. TGF-β1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study. J Oral Pathol Med. 2013 May;42(5):415–23.

Anigol P, Kamath VV, Satelur K, Anand N, Yerlagudda K. Amelogenin in odontogenic cysts and tumors: An immunohistochemical study. Natl J Maxillofac Surg. 2014 Jul-Dec;5(2):172–9.

Carreón-Burciaga RG, González-González R, Molina-Frechero N, López-Verdín S, Pereira-Prado V, Bologna-Molina R. Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas. Anal Cell Pathol . 2018 Apr 23;2018:9392632.

Phattarataratip E, Sappayatosok K. The Significance of Relative Claudin Expression in Odontogenic Tumors. Head Neck Pathol. 2020 Jun;14(2):480–8.

Chopra S, Bansal P, Bansal P. Journal of Advanced Medical and Dental Sciences Research| Vol. 8| Issue 1|. J Adv Med Dent Scie Res. 2020;8(1):184-6.

Zhong Y, Guo W, Wang L, Chen X. Molecular markers of tumor invasiveness in ameloblastoma: An update. Ann Maxillofac Surg. 2011 Jul;1(2):145–9.

ELmrini S, Raiteb M, Bahaa Razem, Hassani FZA, Slimani F. Ameloblastoma giant: Diagnosis, treatment and reconstruction: A case report. Ann Med Surg (Lond). 2021 Aug;68:102589.

Downloads

Published

2023-10-31

How to Cite

S, M., & R, M. (2023). Review on Principles and Etiopathogenesis of Ameloblastoma. International Journal of Clinicopathological Correlation, 7(2), 29–33. https://doi.org/10.56501/intjclinicopatholcorrel.v7i2.916

Issue

Section

Review